Search - tctmd.com

Displaying 201 - 220 of 764

Sort: Relevancy | Date

News Daily News

Public Reporting of PCI Mortality Tied to Fewer High-Risk Cases But Better Outcomes

September 24, 2015

News Opinion Fellow Talk

The Faith of ‘Investing’ in Chronic Total Occlusion Interventions

Henry Quevedo, MD

September 22, 2015

News Daily News

RenalGuard Protects TAVR Patients Against AKI Better Than Does Standard Saline

September 22, 2015

News Daily News

Upstream Bivalirudin Best in NSTE-ACS Patients With Planned Invasive Strategy

L.A. McKeown

September 21, 2015

News Industry News

CeloNova Announces FDA Approval to Start a Randomized Trial for the COBRA PzF™ Coronary Stent System

September 21, 2015

News Daily News

Mechanical Circulatory Support in TAVR Tied to Worse Outcomes, Higher Costs

Todd Neale

September 17, 2015

News Daily News

Registry Charts Trends in Mechanical Circulatory Support During PCI

L.A. McKeown

September 14, 2015

News Conference News ESC 2015

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

September 09, 2015

News Daily News

COURAGE Analysis: Patients With Lower Exercise Capacity No More Likely to Benefit from Revascularization

L.A. McKeown

September 09, 2015

News Conference News ESC 2015

UK Registry: No Relationship Between Hospital PCI Volume and Early Mortality

Yael L. Maxwell

September 01, 2015

News Conference News ESC 2015

Meta-analysis: Long-Term DAPT Beneficial for Patients With History of MI

Yael L. Maxwell

August 31, 2015

News Daily News

DES Patients Who Bleed After Hospital Discharge Face Higher Mortality Risk

Todd Neale

August 31, 2015

News Conference News ESC 2015

Analyses Suggest Prasugrel Causes No Excess Bleeding in Stable CAD Patients

Caitlin E. Cox

August 31, 2015

News Daily News

Registry Study Suggests Absorb BVS Matches DES in Diabetic All-Comers

August 27, 2015

News Daily News

Real-World LVAD Use Promising in Patients Otherwise Considered Too Sick for PCI

L.A. McKeown

August 24, 2015

News Daily News

CAD Location May Influence Need for Prolonged DAPT Post-PCI

Caitlin E. Cox

August 24, 2015

Presentation

Percutaneous LVAD for High-Risk PCIs:Real-World vs Clinical-Trial Experience

Presenter: Mauricio G. Cohen

August 21, 2015

News Daily News

Chronic Pacing Linked to Lower Survival After Balloon-Expandable TAVR

August 20, 2015

News Industry News

Abiomed Announces FDA Submission of Impella 2.5, Impella CP & Impella 5.0-LD Pre-Market Approval Supplements

August 18, 2015

News Daily News

High Troponin T Foretells Poor Outcomes in Patients With Type 2 Diabetes, Stable Heart Disease

Todd Neale

August 17, 2015

Advertisement

Public Reporting of PCI Mortality Tied to Fewer High-Risk Cases But Better Outcomes

The Faith of ‘Investing’ in Chronic Total Occlusion Interventions

RenalGuard Protects TAVR Patients Against AKI Better Than Does Standard Saline

Upstream Bivalirudin Best in NSTE-ACS Patients With Planned Invasive Strategy

CeloNova Announces FDA Approval to Start a Randomized Trial for the COBRA PzF™ Coronary Stent System

Mechanical Circulatory Support in TAVR Tied to Worse Outcomes, Higher Costs

Registry Charts Trends in Mechanical Circulatory Support During PCI

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

COURAGE Analysis: Patients With Lower Exercise Capacity No More Likely to Benefit from Revascularization

UK Registry: No Relationship Between Hospital PCI Volume and Early Mortality

Meta-analysis: Long-Term DAPT Beneficial for Patients With History of MI

DES Patients Who Bleed After Hospital Discharge Face Higher Mortality Risk

Analyses Suggest Prasugrel Causes No Excess Bleeding in Stable CAD Patients

Registry Study Suggests Absorb BVS Matches DES in Diabetic All-Comers

Real-World LVAD Use Promising in Patients Otherwise Considered Too Sick for PCI

CAD Location May Influence Need for Prolonged DAPT Post-PCI

Percutaneous LVAD for High-Risk PCIs:Real-World vs Clinical-Trial Experience

Chronic Pacing Linked to Lower Survival After Balloon-Expandable TAVR

Abiomed Announces FDA Submission of Impella 2.5, Impella CP & Impella 5.0-LD Pre-Market Approval Supplements

High Troponin T Foretells Poor Outcomes in Patients With Type 2 Diabetes, Stable Heart Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content